Understanding WHO’s Risk-Based Inspection Model
Understanding WHO’s Risk-Based Inspection Model Decoding WHO’s Risk-Based Inspection Model for GMP Oversight In the evolving landscape of pharmaceutical regulation, resource-efficient oversight is critical. The World Health Organization (WHO) has adopted a risk-based inspection model under its Prequalification Programme (PQP) to prioritize GMP inspections for pharmaceutical manufacturers. This model helps determine inspection frequency, scope, and…
Read More “Understanding WHO’s Risk-Based Inspection Model” »